FINWIRES · TerminalLIVE
FINWIRES

$WGS

4 stories mentioning WGSUpdated 32d ago

Every FINWIRES story that references WGS, newest first.

Insider Trading

GeneDx Holdings Insider Bought Shares Worth $13,765,345, According to a Recent SEC Filing

Keith A. Meister, 10% Owner, Director, on May 13, 2026, executed a purchase for 351,273 shares in GeneDx Holdings (WGS) for $13,765,345. Following the Form 4 filing with the SEC, Meister has control over a total of 5,137,843 Class A common shares of the company, with 20,129 shares held directly and 5,117,714 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1818331/000101143826000351/xslF345X05/form4.xml

$WGS
Insider Trading

Genedx Holdings Insider Bought Shares Worth $46,806,729, According to a Recent SEC Filing

Keith A. Meister, 10% Owner, Director, on May 07, 2026, executed a purchase for 1,205,147 shares in Genedx Holdings (WGS) for $46,806,729. Following the Form 4 filing with the SEC, Meister has control over a total of 4,786,570 Class A common shares of the company, with 20,129 shares held directly and 4,766,441 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1818331/000101143826000276/xslF345X05/form4.xml

$WGS
Wire

Top Midday Decliners

GeneDx (WGS) sank 50% amid heavy trading after the company reported late Monday a swing to Q1 adjusted loss and lowered its 2026 revenue outlook.More than 8.1 million shares of the company traded intraday compared with a daily average of about 753,000.BellRing (BRBR) reported fiscal Q2 adjusted earnings and sales below market expectations and lowered its full-year 2026 net revenue guidance on Tuesday.Shares slipped 41% following a surge in intraday trading volume to over 16 million from a daily average of about 3.6 million.Huntington Ingalls Industries (HII) shares fell 12% in Tuesday trading after reporting flat Q1 earnings per share.Over 798,000 shares traded intraday versus a daily average of roughly 487,000.Price: $34.22, Change: $-33.71, Percent Change: -49.63%

$BRBR$HII$WGS
Wire

GeneDx Q1 Swings to Adjusted Loss, Revenue Rises; 2026 Revenue Guidance Lowered; Shares Fall

GeneDx (WGS) reported Monday Q1 adjusted loss of $0.28 per diluted share, swinging from an adjusted earnings of $0.31 a year earlier.Analysts polled by FactSet expected loss of $0.02.Revenue for the quarter ended March 31 was $102.3 million, up from $87.1 million a year earlier.Analysts surveyed by FactSet expected $112.5 million.For Q2, the company expects revenue of $110 million to $112 million. Analysts expect $130.3 million.The company now expects 2026 revenue of $475 million to $490 million, down from $540 million to $555 million expected earlier. Analysts expect $550.0 million.Shares of the company were down over 45% during after-hours activity.

$WGS

Track with the FINWIRES app suite

FolioX
FolioX
Track WGS in your portfolio
WheelAI
WheelAI
Analyze WGS options with the wheel strategy
StockInsider
StockInsider
See market sentiment on WGS